• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/11/21 10:23:16 AM ET
    $DFPH
    Business Services
    Finance
    Get the next $DFPH alert in real time by email
    SC 13G/A 1 p21-0510sc13ga.htm DFP HEALTHCARE ACQUISITIONS CORP.
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
     
     

    DFP Healthcare Acquisitions Corp.

     

    (Name of Issuer)
     
     

    Class A Common Stock, par value $0.0001 per share

     

    (Title of Class of Securities)
     
     

    23343Q100

     

    (CUSIP Number)
     
     

    December 31, 2020

     

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ý Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 12 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 23343Q10013G/APage 2 of 12 Pages

     

    1

    NAME OF REPORTING PERSON

    M. H. Davidson & Co.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    New York

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    13,482

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    13,482

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    13,482

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0.06%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 23343Q10013G/APage 3 of 12 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Davidson Kempner Partners

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    New York

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    225,020

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    225,020

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    225,020

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    1.11%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 23343Q10013G/APage 4 of 12 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Davidson Kempner Institutional Partners, L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    566,579

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    566,579

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    566,579

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    2.46%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 23343Q10013G/APage 5 of 12 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Davidson Kempner International, Ltd.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    British Virgin Islands

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    604,967

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    604,967

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    604,967

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    2.63%

    12

    TYPE OF REPORTING PERSON

    CO

             

     

     

    CUSIP No. 23343Q10013G/APage 6 of 12 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Davidson Kempner Capital Management LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,440,048

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,440,048

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,440,048

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    6.26%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 23343Q10013G/APage 7 of 12 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Anthony A. Yoseloff

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,440,048

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,440,048

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,440,048

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    6.26%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

    CUSIP No. 23343Q10013G/APage 8 of 12 Pages

     

    Item 1 (a). NAME OF ISSUER
       
      DFP Healthcare Acquisitions Corp. (the “Issuer”).

     

    Item 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
       
      780 Third Avenue, 37th Floor, New York, New York 10017.

     

    Item 2(a). NAME OF PERSON FILING

     

      This Statement is filed by each of the entities and persons listed below, all of whom together are referred to herein as the “Reporting Persons”:

     

      (i) M. H. Davidson & Co., a New York limited partnership (“CO”). M.H. Davidson & Co. GP, L.L.C., a Delaware limited liability company, is the general partner of CO. DKCM (as defined below) is responsible for the voting and investment decisions of CO;
         
      (ii) Davidson Kempner Partners, a New York limited partnership (“DKP”). MHD Management Co., a New York limited partnership (“MHD”), is the general partner of DKP and MHD Management Co. GP, L.L.C., a Delaware limited liability company, is the general partner of MHD.  DKCM is responsible for the voting and investment decisions of DKP;
         
      (iii) Davidson Kempner Institutional Partners, L.P., a Delaware limited partnership (“DKIP”). Davidson Kempner Advisers Inc., a New York corporation, is the general partner of DKIP. DKCM is responsible for the voting and investment decisions of DKIP;
         
      (iv) Davidson Kempner International, Ltd., a British Virgin Islands business company (“DKIL”).  DKCM is the investment manager of DKIL and is responsible for the voting and investment decisions of DKIL;
         
      (v) Davidson Kempner Capital Management LP, a Delaware limited partnership and a registered investment adviser with the U.S. Securities and Exchange Commission, acts as investment manager to each of CO, DKP, DKIP and DKIL (“DKCM”) either directly or by virtue of a sub-advisory agreement with the investment manager of the relevant fund. DKCM GP LLC, a Delaware limited liability company, is the general partner of DKCM. The managing members of DKCM are Anthony A. Yoseloff, Eric P. Epstein, Conor Bastable, Shulamit Leviant, Morgan P. Blackwell, Patrick W. Dennis, Gabriel T. Schwartz, Zachary Z. Altschuler, Joshua D. Morris and Suzanne K. Gibbons; and
         
      (vi) Anthony A. Yoseloff, through DKCM, is responsible for the voting and investment decisions relating to the securities held by CO, DKP, DKIP and DKIL reported herein.

     

    CUSIP No. 23343Q10013G/APage 9 of 12 Pages

     

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
       
      The address of the principal business office of each of the Reporting Persons is c/o Davidson Kempner Capital Management LP, 520 Madison Avenue, 30th Floor, New York, New York 10022.

     

    Item 2(c). CITIZENSHIP

     

      (i) CO – a New York limited partnership
         
      (ii) DKP – a New York limited partnership
       
      (iii) DKIP – a Delaware limited partnership
       
      (iv) DKIL – a British Virgin Islands business company
       
      (v) DKCM – a Delaware limited partnership
       
      (vi) Anthony A. Yoseloff – United States

     

    Item 2(d). TITLE OF CLASS OF SECURITIES
       
      Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”)

     

    Item 2(e). CUSIP NUMBER:
       
      23343Q100

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act;
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act;
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act;
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940;
      (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨

    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

     

    CUSIP No. 23343Q10013G/APage 10 of 12 Pages

     

      (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
      (h) ¨

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

      (i) ¨

    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

     

      (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:_________________________  
         
    Item 4. OWNERSHIP.
       
      The percentages used in this Schedule 13G/A are calculated based upon 23,000,000 shares of Class A Common Stock outstanding as of November 13, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020, filed with the Securities and Exchange Commission on November 13, 2020.
       
      The information required by Items 4(a) – (c)  is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      Not applicable.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      Not applicable.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    CUSIP No. 23343Q10013G/APage 11 of 12 Pages

     

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.
       
      Each of the Reporting Persons hereby makes the following certification:
       
      By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. 23343Q10013G/APage 12 of 12 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE:  February 11, 2021 /s/ Anthony A. Yoseloff
      ANTHONY A. YOSELOFF, (i) individually, (ii) as Executive Managing Member of:  (a) Davidson Kempner Capital Management LP, (x) for itself and (y) as Investment Manager of Davidson Kempner International, Ltd., (b) M.H. Davidson & Co. GP, L.L.C., as General Partner of M.H. Davidson & Co. and (c) MHD Management Co. GP, L.L.C., as General Partner of MHD Management Co. as General Partner of Davidson Kempner Partners and (iii) as Director of Davidson Kempner Advisers Inc. as General Partner of Davidson Kempner Institutional Partners, L.P.
       
       

     

     

    Get the next $DFPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DFPH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DFPH
    SEC Filings

    View All

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)

    8-K/A - Oncology Institute, Inc. (0001799191) (Filer)

    11/22/21 5:18:03 PM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Registrant’s Certifying Accountant, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Other Events, Financial Statements and Exhibits

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    11/18/21 5:29:51 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 25-NSE filed by DFP Healthcare Acquisitions Corp.

    25-NSE - DFP HEALTHCARE ACQUISITIONS CORP. (0001799191) (Subject)

    11/12/21 4:20:20 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Oncology Institute Physician, Dr. John Khoury, Receives 40 Under 40 in Cancer Award

    This is the second year in a row a TOI physician was recognized The Oncology Institute (TOI) is proud to announce that Dr. John Khoury was recently awarded the "40 Under 40 in Cancer" award by the Association for Value-Based Cancer Care. This is the second year in a row a TOI physician was recognized for this honor. Dr. Omkar Marathe was selected for the distinction in 2020. "It's an honor to be part of such a distinguished list of young oncology professionals and leaders who work very hard to improve the lives of those affected by cancer," said Dr. Khoury. Dr. John Khoury is a triple board-certified physician who joined The Oncology Institute in 2020. He completed his residency and fell

    11/9/21 9:15:00 AM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute

    Special Meeting of Stockholders Scheduled for November 12, 2021 DFP Healthcare Acquisitions Corp. ("DFP") (NASDAQ:DFPH) announced today that it has scheduled the special meeting of its stockholders (the "Special Meeting") for November 12, 2021 at 10:00 a.m., Eastern Time, to approve the proposed business combination (the "Business Combination") with The Oncology Institute ("TOI" or the "Company"), the U.S. market leader in providing value-based oncology care. DFP also announced that it has filed its definitive proxy statement/prospectus for the Special Meeting and has commenced mailing the definitive proxy statement/prospectus to its stockholders of record as of September 23, 2021, the re

    10/22/21 4:05:00 PM ET
    $DFPH
    Business Services
    Finance

    The Oncology Institute of Hope and Innovation (TOI) Expands to San Diego County

    Two state-of-the-art clinics opening in Vista and Chula Vista with a third in Hillcrest slated for later this year The Oncology Institute of Hope and Innovation (TOI) began seeing patients this week at two new locations in Vista and Chula Vista, marking the community-based oncology provider's entry into San Diego County. A third location in Hillcrest is slated to open in the fall. Founded in 2007, TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs

    8/4/21 12:05:00 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider M33 Growth I L.P. claimed ownership of 15,256,383 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:38:03 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 3: New insider Havencrest Healthcare Partners, L.P. claimed ownership of 15,662,794 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:28:08 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 4: Sarin Ravi Yang was granted 4,109,771 shares (Amendment)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:15:17 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:41:54 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:25:01 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:19:36 PM ET
    $DFPH
    Business Services
    Finance